-- The 8th China Venous Surgery Forum and the China Venous Congress of the International Union of Phlebiology were successfully held in Zhengzhou
From December 8 to 10, 2017, it was jointly organized by the Vascular Surgery Group of the Surgery Branch of the Chinese Medical Association, the Chinese Phlebiology Branch of the International Union of Phlebiology, and the Henan Medical Association. The First Affiliated Hospital of Zhengzhou University and Beijing Millennium Temple Hospital affiliated to Capital Medical University jointly hosted the 8th China Venous Surgery Forum and the China Venous Congress of the International Phlebology Union, and the second Annual meeting of Henan Vascular Surgery in Zhengzhou International Convention and Exhibition Center. More than 1,500 vascular surgery experts from all over the country gathered in Greentown to celebrate the "venous feast"!
Adhering to the concept of "strengthening basic diagnosis and treatment, standardizing clinical operations, serving front-line doctors, tracking major research, and comprehensively displaying the new progress in the diagnosis and treatment of vascular diseases at home and abroad", this meeting analyzed the new hot spots and new problems of venous diseases such as varicose veins, venous thrombosis, venous malformation, and hemodialysis access. The new technology, new idea and new progress in the treatment of common and frequently-occurring diseases are discussed in depth. During the conference, after the end of each speaker\'s speech, the experts and scholars who listened to the topic will ask questions and discuss the topic content. It is this scientific spirit of seeking truth and pursuing truth that makes the rapid development of vascular surgery in China and the diagnosis and treatment of diseases reach the international leading level.
At the meeting, experts from Beijing Anzhen Hospital affiliated to Capital Medical University once again emphasized in the topic "Application of drug Therapy in Venous diseases" that aescinoside is a representative drug, which has the effect of reducing vascular permeability, increasing venous tension, promoting venous blood return, and reducing edema, and explained the mechanism of Xingyin products in detail. Xingyin products as a classic representative of intravenous active drugs, long-term sales, reputation, is determined by its excellent clinical effect, of course, can not be separated from the experts and scholars of word of mouth, we still have to increase academic promotion as always, so that more doctors, experts remember Xingyin products, for more patients to relieve the pain!